TheraRadar

Pharma Intelligence, Simplified

← All Targets

Estrogen receptor

1 drugs
Market Leader
MYFEMBREE
SUMITOMO PHARMA AM
3
approved indications
1
Approved Drugs
1
Companies
3
Indications
0
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (1 companies)
All 1 approved drugs
Therapeutic area breakdown
Full indication list (3 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

SUMITOMO PHARMA AM 1 drug

By Therapeutic Area

Other 1 drugs